A peer-reviewed result published in the journal "The Lancet" finds Russia's Sputnik V vaccine to be 91.6% effective against symptomatic COVID-19 infection. It is the third major vaccine candidate to exceed 90% efficacy, along with the Pfizer and Moderna vaccines.
A peer-reviewed results published in the journal "The Lancet" finds the Russian COVID-19 vaccine to be 91.6% effective against symptomatic COVID-19 infection. It is the third major vaccine candidate to succeed 90% efficacy, along with the Pfizer and Moderna vaccines.
A peer-reviewed results published in the journal "The Lancet" finds Russia'sSputnik V to be 91.6% effective against symptomatic COVID-19 infection. It is the third major vaccine candidate to succeed 90% efficacy, along with the Pfizer and Moderna vaccines.
A peer-reviewed result published in the journal "The Lancet" finds Russia's Sputnik V vaccineto be 91.6% effective against symptomatic COVID-19 infection. It is the third major vaccine candidate to exceed 90% efficacy, along with the Pfizer and Moderna vaccines.
